Amicus Therapeutics Inc FOLD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:20 PM EDT
10.17UNCH (UNCH)
Volume
105,720
Close
10.17quote price arrow down-0.37 (-3.51%)
Volume
3,896,800
52 week range
9.70 - 14.57
Loading...
  • Open10.40
  • Day High10.47
  • Day Low10.02
  • Prev Close10.54
  • 52 Week High14.57
  • 52 Week High Date12/28/23
  • 52 Week Low9.70
  • 52 Week Low Date11/10/23

Key Stats

  • Market Cap3.004B
  • Shares Out295.38M
  • 10 Day Average Volume2.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-28.33

KEY STATS

  • Open10.40
  • Day High10.47
  • Day Low10.02
  • Prev Close10.54
  • 52 Week High14.57
  • 52 Week High Date12/28/23
  • 52 Week Low9.70
  • 52 Week Low Date11/10/23
  • Market Cap3.004B
  • Shares Out295.38M
  • 10 Day Average Volume2.87M
  • Dividend-
  • Dividend Yield-
  • Beta0.78
  • YTD % Change-28.33

RATIOS/PROFITABILITY

  • EPS (TTM)-0.51
  • P/E (TTM)-19.76
  • Fwd P/E (NTM)2,542.50
  • EBITDA (TTM)-68.204M
  • ROE (TTM)-107.04%
  • Revenue (TTM)399.356M
  • Gross Margin (TTM)90.65%
  • Net Margin (TTM)-37.96%
  • Debt To Equity (MRQ)242.15%

EVENTS

  • Earnings Date05/08/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amicus Therapeutics Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Amicus Therapeutics, Inc. is a biotechnology company, which is focused on discovering, developing, and delivering novel medicines for rare diseases. Its two marketed therapies are Galafold, the first oral monotherapy for people living with Fabry disease who have amenable genetic variants, and Pombiliti + Opfolda, a novel treatment designed to improve uptake of active enzyme into key disease relevant tissues for adults living with late-onset Pompe disease. As an orally...
Michael Raab
Independent Chairman of the Board
Bradley Campbell
President & Chief Operating Officer
Simon Harford
Chief Financial Officer
Samantha Prout CPA
Chief Accounting Officer, Controller
Address
3675 Market Street
Philadelphia, PA
19104
United States

Top Peers

SYMBOLLASTCHG%CHG
RARE
Ultragenyx Pharmaceutical Inc
43.85-0.43-0.97%
AXSM
Axsome Therapeutics Inc
71.52+0.35+0.49%
INSM
Insmed Inc
24.92-0.89-3.45%
IMCR
Immunocore Holdings PLC
58.00-0.47-0.80%
MOR
MorphoSys AG
18.13+0.08+0.44%